Study links dog and human aging biomarkers
Bottom line
Dogs and people may share more of the biology of aging than many veterinarians assumed. A new Dog Aging Project study, published in The Journals of Gerontology: Series A, found that blood metabolites linked to all-cause mortality in dogs tracked closely with the same mortality signals reported in human studies. The analysis drew on longitudinal metabolomic data from 937 dogs in the project’s Precision Cohort, part of a broader U.S. study of more than 50,000 companion dogs. Texas A&M and University of Washington researchers say the findings strengthen the case for dogs as a translational model for human aging research. (academic.oup.com)
Why it matters: For veterinary professionals, the study adds weight to metabolomics as a practical path toward earlier identification of aging-related risk, frailty, and disease trajectories in dogs. Because dogs share human environments, healthcare systems, and many age-related conditions, but age much faster, they may help generate clinically relevant aging insights on a shorter timeline than human cohort studies alone. That could eventually inform prognostic tools, preventive care strategies, and future healthspan-focused interventions in companion animal medicine. (academic.oup.com)
What to watch: As the Dog Aging Project continues following enrolled dogs across life stages, researchers say the next step is to test whether metabolomic and other multi-omic biomarkers can predict specific age-related diseases, not just mortality. (academic.oup.com)
Key facts
- Study type
- Longitudinal metabolomic analysis
- Publication
- The Journals of Gerontology: Series A
- Publication date
- March 16, 2026
- Sample size
- 937 dogs
- Cohort
- Dog Aging Project Precision Cohort
- Metabolites evaluated
- 133
- Main finding
- Blood metabolites linked to all-cause mortality in dogs closely matched mortality signals reported in human studies
- Statistical result
- About 17% of measured metabolites were associated with mortality, and 23 met a false discovery rate below 5%
- Study limitation
- Focused on all-cause mortality associations, not intervention efficacy or ready-for-clinic diagnostics
A new Dog Aging Project paper is sharpening the scientific case for dogs as a model for human aging. In research published March 16, 2026, in The Journals of Gerontology: Series A, investigators reported that blood metabolites associated with all-cause mortality in dogs were strongly aligned with mortality-associated metabolites previously identified in humans. Texas A&M highlighted the work in a June 8, 2026, news release, framing it as evidence that dogs and humans share key features of aging biology. (academic.oup.com)
The work builds on the long-running Dog Aging Project, a large open-science effort launched by researchers at institutions including Texas A&M and the University of Washington to study how genetics, environment, and lifestyle shape healthy aging in companion dogs. The project was designed around a simple but powerful premise: dogs live in human-built environments, receive sophisticated veterinary care, develop many of the same age-related diseases as people, and age on a much shorter timeline. That makes them attractive as a translational model for geroscience. (nature.com)
In the new study, researchers analyzed plasma samples from 937 dogs in the Dog Aging Project’s Precision Cohort and evaluated 133 metabolites using longitudinal survival models that controlled for age, sex, weight, creatinine, and genetic relatedness. The paper reports that about 17% of measured metabolites were associated with mortality, with 23 reaching a false discovery rate below 5%. The team then compared those dog findings against multiple published human mortality studies and found a strong positive correlation in the direction and magnitude of metabolite effects across species. (academic.oup.com)
The institutional messaging around the paper emphasized both the scientific surprise and the translational opportunity. In the University of Washington release, lead author Ben Harrison said the overlap was “shocking,” while senior author Daniel Promislow said dogs let researchers learn about aging far more quickly than human cohorts can. Texas A&M’s release similarly quoted Kate Creevy, chief veterinary officer of the Dog Aging Project and a professor at the College of Veterinary Medicine & Biomedical Sciences, saying molecules associated with earlier or later death were very similar in dogs and people. (newsroom.uw.edu)
The findings also fit with a broader stream of Dog Aging Project research. Earlier project publications have examined age-related metabolomic shifts, protein catabolites as blood-based aging biomarkers, and even social determinants of health in companion dogs. Together, that body of work suggests the field is moving beyond lifespan alone and toward measurable indicators of healthspan, biological age, and risk stratification. That trend matters as veterinary medicine increasingly intersects with preventive care, chronic disease management, and pet parent demand for evidence-based longevity guidance. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For practicing veterinarians and industry stakeholders, this isn’t an immediately practice-changing paper, but it is an important signal. If metabolomic signatures can be validated and tied to specific clinical outcomes, they could eventually support earlier screening for age-related decline, better monitoring of senior patients, and more targeted counseling around nutrition, lifestyle, and preventive care. It also reinforces the value of companion dogs in comparative medicine, which may attract more research investment into diagnostics, biomarkers, and therapeutics that benefit both canine patients and human medicine. (academic.oup.com)
There are still important caveats. The current paper focuses on all-cause mortality associations, not intervention efficacy or ready-for-clinic diagnostics, and metabolomic signals can reflect multiple physiological processes, including kidney-related changes noted by the authors. Even so, the study gives the field a stronger longitudinal foundation than many earlier cross-sectional biomarker reports. (academic.oup.com)
What to watch: The next phase is whether the Dog Aging Project can turn these broad mortality signals into disease-specific, clinically actionable biomarkers, and whether those markers help evaluate future healthspan interventions in dogs, including ongoing geroscience work tied to the project’s broader multi-omic platform. (academic.oup.com)